Q&A: Is Less More - Rethinking Breast Cancer Treatment

In the latest Breast Cancer Trials Q&A, moderated by Journalist and Author Annabel Crabb, we explore optimised treatment.
Our panel of experts discuss the EXPERT, OPTIMA and PROSPECT clinical trials, research into identifying patients who may benefit from receiving less treatment but still receive the same outcomes, the psychological impact of the fear of breast cancer recurrence and the patient perspective of having optimised treatment.
Our panel is: Professor Boon Chua, Ms Maragart Lopreiato, Ms Michelle Sinclair and Dr Belinda Kiely.
----------------------------------------------------------------
Breast Cancer Trials is a group of world-leading breast cancer doctors and researchers based in Australia and New Zealand committed to exploring and finding better treatments for people affected by breast cancer through clinical trials research.
Please like this video then visit www.breastcancertrials.org.au to find out more about our current breast cancer clinical trials that may be suitable for you, and ways in which you can help support breast cancer research.
----------------------------------------------------------------
SUBSCRIBE TO OUR TH-cam CHANNEL
/ @breastcancertrials
LET'S CONNECT
Email ►[e-mail]
Tel [phone]
WWW ► www.breastcance...
Linkedin ► / 5057154
Twitter ► / bctrialsanz
Facebook ► / breastcancertrials
Instagram ► / breastcancertrials

[@debraottway189]

interesting they mention Hormone Blocking medication as the first treatment. I personally had my breast cancer removed surgically and for my 1% promise of the cancer not returning from tamoxifen, I chose to stop medication. the side effects were drastic